InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by Oliviero James F III, Chairman & CEO. Insider active across 1 companies, notably Checkpoint Therapeutics, Inc.. Cumulatively, 4 reports have been published. Total volume traded: €236k. The latest transaction was filed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€235,634228,000 shares@ €1.033522.1% of flow
COMMON STOCK
SEC:0001104659-22-076976:0·
€831,465302,777 shares@ €2.746177.9% of flow
COMMON STOCK
SEC:0001104659-22-049156:0·
0455,000 shares0
COMMON STOCK (RESTRICTED)
SEC:0001104659-22-010997·
0455,000 shares0
COMMON STOCK (RESTRICTED)
SEC:0001104659-22-010997:0·
4 of 4 declarations
About Oliviero James F III
Oliviero James F III serves as President, Chief Executive Officer, and Board Member of Checkpoint Therapeutics, Inc. In this role, he leads the company's operations and develops strategies to achieve growth objectives. His expertise in the biopharmaceutical field is essential for Checkpoint, which focuses on developing innovative cancer treatments. Oliviero is committed to improving patient health through advanced therapeutic solutions.
